Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Sacubitril/Valsartan: Potentia...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19

Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19

Bibliographic Details
Main Authors: Speranza Rubattu, Giovanna Gallo, Massimo Volpe
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
COVID-19
natriuretic peptide
ARNi
cardiovascular diseases
HFrEF—heart failure with reduced ejection fraction
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.616564/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.616564/full

Similar Items

  • Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease
    by: Chih‐Yuan Niu, et al.
    Published: (2022-09-01)
  • Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)
    by: Przemysław Żelazny, et al.
    Published: (2022-09-01)
  • Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study
    by: Dong-Yi Chen, et al.
    Published: (2021-11-01)
  • Sacubitril/Valsartan vs ACE Inhibitors or ARBs
    by: Endurance Evbayekha, MD, et al.
    Published: (2025-03-01)
  • A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era
    by: Speranza Rubattu, et al.
    Published: (2021-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs